Pharmacy on-site overdose protocols and prevention of overdose

References

• Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010–2016. JAMA. 2018;319(17):1819–1821.
   PubMed Web of Science ®Google Scholar
• Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–116.
   PubMed Web of Science ®Google Scholar
• Bell A, Bennett AS, Jones TS, Doe-Simkins M, Williams LD. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Subst Abus. 2019;40(1):52–55.
   PubMed Web of Science ®Google Scholar
• Davis C, Carr D. State legal innovations to encourage naloxone dispensing. J Am Pharm Assoc (2003). 2017;57(2):S180–S184.
   PubMed Web of Science ®Google Scholar
• Wheeler E, Jones T, Gilbert M, Davidson P. Opioid overdose prevention programs providing naloxone to laypersons — United States, 2014. Morb Mortal Wkly Rep. 2015;64(23):631–635.
   PubMed Web of Science ®Google Scholar
• Meyerson BE, Agley JD, Davis A, et al. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. Drug Alcohol Depend. 2018;188:187–192.
   PubMed Web of Science ®Google Scholar
• Goodin A, Fallin-Bennett A, Green T, Freeman PR. Pharmacists’ role in harm reduction: a survey assessment of Kentucky community pharmacists’ willingness to participate in syringe/needle exchange. Harm Reduct J. 2018;15(1):4.
   PubMedGoogle Scholar
• Lasnier B, Brochu S, Boyd N, Fischer B. A heroin prescription trial: case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods. Int J Drug Policy. 2010;21(1):28–35.
   PubMed Web of Science ®Google Scholar
• Day CA, White B, Haber PS. The impact of an automatic syringe dispensing machine in inner-city Sydney, Australia: no evidence of a ‘honey-pot’ effect. Drug Alcohol Rev. 2016;35(5):637–643.
   PubMed Web of Science ®Google Scholar
• Stopka TJ, Geraghty EM, Azari R, Gold EB, DeRiemer K. Is crime associated with over-the-counter pharmacy syringe sales? Findings from Los Angeles, California. Int J Drug Policy. 2014;25(2):244–250.
   PubMed Web of Science ®Google Scholar
• Capraro GA, Rebola CB. The NaloxBox Program in Rhode Island: a model for community-access naloxone. Am J Public Health. 2018;108(12):1649–1651.
   PubMed Web of Science ®Google Scholar
• Islam M, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19(6):436–441.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Edwards C, Davey-Rothwell MA, Yang C, Tobin KE. The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland. Subst Abus. 2018;39(3):384–389.
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Tracy M, Galea S. Circumstances and witness characteristics associated with overdose fatality. Ann Emerg Med. 2009;54(4):618–624.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• National Safety Council. Deaths in public places, 2017. Injury Facts Web site. https://injuryfacts.nsc.org/home-and-community/deaths-in-public-places/introduction/. Published 2019. Accessed January 1, 2020.
   Google Scholar
• Wallace B, Barber K, Pauly BB. Sheltering risks: implementation of harm reduction in homeless shelters during an overdose emergency. Int J Drug Policy. 2018;53:83–89.
   PubMed Web of Science ®Google Scholar
• Dankowski T. Addressing the opioid epidemic: public libraries are crafting harm reduction responses with community partners. “The Scoop”. American Library Association. June 25, 2019. https://americanlibrariesmagazine.org/blogs/the-scoop/addressing-opioid-epidemic/.
   Google Scholar
• Wolfson-Stofko B, Gwadz MV, Elliott L, Bennett AS, Curtis R. “Feeling confident and equipped”: evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City. Drug Alcohol Depend. 2018;192:362–370.
   PubMed Web of Science ®Google Scholar
• Rhode Island General Laws § 11-56-1 2012. Title 11 – Criminal Offenses; Chapter 11-56 - Duty to Render Assistance; Chapter 11-56-1 - Duty to assist. In: Rhode Island; 2012.
   Google Scholar
• Minnesota Statutes Section 604A.01. GOOD SAMARITAN LAW. In: Minnesota; 2019.
   Google Scholar
• Patrick SW, Schumacher RE, Horbar JD, et al. Improving care for neonatal abstinence syndrome. Pediatrics. 2016;137(5):e20153835–e20153835.
   PubMed Web of Science ®Google Scholar
• Samuels EA, McDonald JV, McCormick M, Koziol J, Friedman C, Alexander-Scott N. Emergency department and hospital care for opioid use disorder: implementation of statewide standards in Rhode Island, 2017–2018. Am J Public Health. 2019;109(2):263–266.
   PubMed Web of Science ®Google Scholar
• Burstein D, Baird J, Bratberg J, et al. Pharmacist attitudes toward pharmacy-based naloxone: a cross-sectional survey study. J Am Pharm Assoc. 2019. doi:10.1016/j.japh.2019.11.004
   Google Scholar
• Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019;179(6):805.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Naloxone: The opioid reversal drug that saves lives. How healthcare providers and patients can better utilize this life-saving drug. In: Washington, DC; 2018.
   Google Scholar
• Puzantian T, Gasper JJ. Provision of naloxone without a prescription by California pharmacists 2 years after legislation implementation. JAMA. 2018;320(18):1933–1934.
   PubMed Web of Science ®Google Scholar
• Lozo KW, Nelson LS, Ramdin C, Calello DP. Naloxone deserts in NJ cities: sociodemographic factors which may impact retail pharmacy naloxone availability. J Med Toxicol. 2019;15(2):108–111.
   PubMed Web of Science ®Google Scholar
• Evoy KE, Hill LG, Groff L, Mazin L, Carlson CC, Reveles KR. Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas. JAMA. 2018;320(18):1934–1937.
   PubMed Web of Science ®Google Scholar
• Starr LM. Automated external defibrillation in the occupational setting. J Occup Environ Med. 2002;44(1):2–7.
   PubMed Web of Science ®Google Scholar
• Starr LM. Automated external defibrillation in the occupational setting. J Occup Environ Med. 2012;54(9):1170–1176.
   PubMed Web of Science ®Google Scholar